Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The influenza virus hemagglutinin (HA) protein is a trimeric glycoprotein found on the surface of influenza viruses, including seasonal strains. It mediates viral attachment to host cells and fusion of the viral envelope with the host cell membrane. HA is a major target for neutralizing antibodies, and its high variability due to antigenic drift and shift necessitates regular updates to seasonal flu vaccines.
Antibodies bind to HA, blocking receptor binding and/or membrane fusion, thus neutralizing the virus.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza Virus Hemagglutinin Protein (Seasonal Strains) (HA).